Research ArticleOriginal Research

Predictors of Outcome in 216 Subjects With ARDS Treated With Inhaled Epoprostenol

Jose Pacheco, Heather Arnold, Lee Skrupky, Peggy Watts, Scott T Micek and Marin H Kollef
Respiratory Care August 2014, 59 (8) 1178-1185; DOI: https://doi.org/10.4187/respcare.02939

REFERENCES

  1. 1.↵
    1. Matthay MA,
    2. Ware LB,
    3. Zimmerman GA
    . The acute respiratory distress syndrome. J Clin Invest 2012;122(8):2731-2740.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Fanelli V,
    2. Vlachou A,
    3. Ghannadian S,
    4. Simonetti U,
    5. Slutsky AS,
    6. Zhang H
    . Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis 2013;5(3):326-334.
    OpenUrlPubMed
  3. 3.↵
    The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301-1308.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.
    1. Amato MB,
    2. Barbas CS,
    3. Medeiros DM,
    4. Magaldi RB,
    5. Schettino GP,
    6. Lorenzi-Filho G,
    7. et al
    . Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338(6):347-354.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Villar J,
    2. Kacmarek RM,
    3. Pérez-Méndez L,
    4. Aguirre-Jaime A
    . A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006;34(5):1311-1318.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Walmrath D,
    2. Schneider T,
    3. Schermuly R,
    4. Olschewski H,
    5. Grimminger F,
    6. Seeger W
    . Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;153(3):991-996.
    OpenUrlPubMedWeb of Science
  7. 7.
    1. Ferguson ND,
    2. Cook DJ,
    3. Guyatt GH,
    4. Mehta S,
    5. Hand L,
    6. Austin P,
    7. et al
    . High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013;368(9):795-805.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Papazian L,
    2. Forel JM,
    3. Gacouin A,
    4. Penot-Ragon C,
    5. Perrin G,
    6. Loundou A,
    7. et al
    . Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107-1116.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Steinberg KP,
    2. Hudson LD,
    3. Goodman RB,
    4. Hough CL,
    5. Lanken PN,
    6. Hyzy R,
    7. et al
    . Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354(16):1671-1684.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Anzueto A,
    2. Baughman RP,
    3. Guntupalli KK,
    4. Weg JG,
    5. Wiedemann HP,
    6. Raventós AA,
    7. et al
    . Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334(22):1417-1421.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Collins SR,
    2. Blank RS
    . Approaches to refractory hypoxemia in acute respiratory distress syndrome: current understanding, evidence, and debate. Respir Care 2011;56(10):1573-1582.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Ranieri VM,
    2. Rubenfeld GD,
    3. Thompson BT,
    4. Ferguson ND,
    5. Caldwell E,
    6. et al
    ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-2533.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Kollef MH,
    2. Napolitano LM,
    3. Solomkin JS,
    4. Wunderink RG,
    5. Bae IG,
    6. Fowler VG,
    7. et al
    . Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. Clin Infect Dis 2008;47(Supp 2):S55-S99.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Knaus WA,
    2. Draper EA,
    3. Wagner DP,
    4. Zimmerman JE
    . APACHE II: a severity of disease classification system. Crit Care Med 1985;13(10):818-829.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Vincent JL,
    2. Moreno R,
    3. Takala J,
    4. Willatts S,
    5. De Mendonça A,
    6. Bruining H,
    7. et al
    . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22(7):707-710.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Taylor RW,
    2. Zimmerman JL,
    3. Dellinger RP,
    4. Straube RC,
    5. Criner GJ,
    6. Davis K Jr.,
    7. et al
    . Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004;291(13):1603-1609.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.
    1. Michael JR,
    2. Barton RG,
    3. Saffle JR,
    4. Mone M,
    5. Markewitz BA,
    6. Hillier K,
    7. et al
    . Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157(5):1372-1380.
    OpenUrlPubMedWeb of Science
  18. 18.
    1. Dellinger RP,
    2. Zimmerman JL,
    3. Taylor RW,
    4. Straube RC,
    5. Hauser DL,
    6. Criner GJ,
    7. et al
    . Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998;26(1):15-23.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.
    1. Troncy E,
    2. Collet JP,
    3. Shapiro S,
    4. Guimond JG,
    5. Blair L,
    6. Ducruet T,
    7. et al
    . Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med 1998;157(5 Pt 1):1483-1488.
    OpenUrlPubMedWeb of Science
  20. 20.↵
    1. Lundin S,
    2. Mang H,
    3. Smithies M,
    4. Stenqvist O,
    5. Frostell C
    . Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. Intensive Care Med 1999;25(9):911-919.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Adhikari NK,
    2. Burns KE,
    3. Friedrich JO,
    4. Granton JT,
    5. Cook DJ,
    6. Meade MO
    . Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and metaanalysis. BMJ 2007;334(7597):779.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Zwissler B,
    2. Kemming G,
    3. Habler O,
    4. Kleen M,
    5. Merkel M,
    6. Haller M,
    7. et al
    . Inhaled epoprostenol (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996;154(6 Pt 1):1671-1677.
    OpenUrlPubMedWeb of Science
  23. 23.↵
    1. Torbic H,
    2. Szumita PM,
    3. Anger KE,
    4. Nuccio P,
    5. LaGambina S,
    6. Weinhouse G
    . Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care 2013;28(5):844-848.
    OpenUrlPubMed
  24. 24.↵
    1. Camporota L,
    2. Sherry T,
    3. Smith J,
    4. Lei K,
    5. McLuckie A,
    6. Beale R
    . Physiological predictors of survival during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care 2013;17(2):R40.
    OpenUrlPubMed
  25. 25.↵
    1. Pappalardo F,
    2. Pieri M,
    3. Greco T,
    4. Patroniti N,
    5. Pesenti A,
    6. Arcadipane A,
    7. et al
    . Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med 2013;39(2):275-281.
    OpenUrlPubMed
  26. 26.↵
    1. Pham T,
    2. Combes A,
    3. Rozé H,
    4. Chevret S,
    5. Mercat A,
    6. Roch A,
    7. et al
    . Extracorporeal membrane oxygenation for pandemic influenza A (H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2013;187(3):276-285.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Murphy CV,
    2. Schramm GE,
    3. Doherty JA,
    4. Reichley RM,
    5. Gajic O,
    6. Afessa B,
    7. et al
    . The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009;136(1):102-109.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Wiedemann HP,
    2. Wheeler AP,
    3. Bernard GR,
    4. Thompson BT,
    5. Hayden D,
    6. et al
    National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354(24):2564-2575.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Boyd JH,
    2. Forbes J,
    3. Nakada TA,
    4. Walley KR,
    5. Russell JA
    . Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011;39(2):259-265.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Maitland K,
    2. Kiguli S,
    3. Opoka RO,
    4. Engoru C,
    5. Olupot-Olupot P,
    6. Akech SO,
    7. et al
    . Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011;364(26):2483-2495.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Gong MN,
    2. Bajwa EK,
    3. Thompson BT,
    4. Christiani DC
    . Body mass index is associated with the development of acute respiratory distress syndrome. Thorax 2010;65(1):44-50.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Anzueto A,
    2. Frutos-Vivar F,
    3. Esteban A,
    4. Bensalami N,
    5. Marks D,
    6. Raymondos K,
    7. et al
    . Influence of body mass index on outcome of the mechanically ventilated patients. Thorax 2011;66(1):66-73.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. De Jong A,
    2. Molinari N,
    3. Sebbane M,
    4. Prades A,
    5. Futier E,
    6. Jung B,
    7. et al
    . Feasibility and effectiveness of prone position in morbidly obese patients with ARDS: a case-control clinical study. Chest 2013;143(6):1554-1561.
    OpenUrlPubMed
  34. 34.↵
    1. Afshari A,
    2. Brok J,
    3. Møller AM,
    4. Wetterslev J
    . Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Cochrane Database Syst Rev 2010;(8):CD007733.
  35. 35.↵
    1. Guérin C,
    2. Reignier J,
    3. Richard JC,
    4. Beuret P,
    5. Gacouin A,
    6. Boulain T,
    7. et al
    . Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368(23):2159-2168.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords